Gallium-mediated siderophore quenching as an evolutionarily robust antibacterial treatment
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVES: Conventional antibiotics select strongly for resistance and are consequently losing efficacy worldwide. Extracellular quenching of shared virulence factors could represent a more promising strategy because (i) it reduces the available routes to resistance (as extracellular action precludes any mutations blocking a drug's entry into cells or hastening its exit) and (ii) it weakens selection for resistance, as fitness benefits to emergent mutants are diluted across all cells in a cooperative collective. Here, we tested this hypothesis empirically. METHODOLOGY: We used gallium to quench the iron-scavenging siderophores secreted and shared among pathogenic Pseudomonas aeruginosa bacteria, and quantitatively monitored its effects on growth in vitro. We assayed virulence in acute infections of caterpillar hosts (Galleria mellonella), and tracked resistance emergence over time using experimental evolution. RESULTS: Gallium strongly inhibited bacterial growth in vitro, primarily via its siderophore quenching activity. Moreover, bacterial siderophore production peaked at intermediate gallium concentrations, indicating additional metabolic costs in this range. In vivo, gallium attenuated virulence and growth-even more so than in infections with siderophore-deficient strains. Crucially, while resistance soon evolved against conventional antibiotic treatments, gallium treatments retained their efficacy over time. CONCLUSIONS: Extracellular quenching of bacterial public goods could offer an effective and evolutionarily robust control strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, gallium (Ga2+) quenching of P. aeruginosa siderophores reduced pathogenesis in a Galleria mellonella model and retained efficacy longer than the conventional antibiotics gentamicin and ciprofloxacin (118).”
From Transition Metals and Virulence in Bacteria (2016) · cites this paper as [118]
Experimental — accuracy not yet measuredIn the citing paper
“For example, gallium (Ga2+) quenching of P. aeruginosa siderophores reduced pathogenesis in a Galleria mellonella model and retained efficacy longer than the conventional antibiotics gentamicin and ciprofloxacin (118).”
From Transition Metals and Virulence in Bacteria (2016) · cites this paper as [118]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
Antibiotics for Emerging Pathogens
Fischbach, M. A., & Walsh, C. T. (2009) · Science · doi:10.1126/science.1176667 · Cited by 1,777 · cited 1×
“Consequently, the therapy will lose efficacy [1, 2].”
Siderophore-Based Iron Acquisition and Pathogen Control
Miethke, M., & Marahiel, M. A. (2007) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00012-07 · Cited by 1,774 · cited 1×
“Siderophores are diffusible molecules with a high affinity for ferric iron (Fe3þ) and are secreted by most bacteria to scavenge this important but generally bio-unavailable form of iron from their environment or, in the case of pathogens, from their host’s own iron-chelating compounds [17].”
BackgroundAnti-virulence strategies to combat bacteria-mediated disease
Rasko, D. A., & Sperandio, V. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3013 · Cited by 1,373 · cited 2×
“‘Antivirulence’ treatments, meanwhile, ostensibly disarm but do not harm pathogens, such that resistant variants should benefit little relative to susceptibles [4].”
BackgroundCooperation and competition in pathogenic bacteria
Griffin, A. S., West, S. A., & Buckling, A. (2004) · Nature · doi:10.1038/nature02744 · Cited by 1,104 · cited 1×
“Low (a) Pyoverdine molecules are shared across the local community [47], so producers of the novel and the ancestral pyoverdine types would benefit similarly.”
Adaptive and Mutational Resistance: Role of Porins and Efflux Pumps in Drug Resistance
Fernández, L., & Hancock, R. E. W. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00043-12 · Cited by 892 · cited 1×
“modified membrane properties to block a drug’s entry into a cell, or upregulated efflux pumps to hasten its exit [15]).”
BackgroundExploiting Quorum Sensing To Confuse Bacterial Pathogens
LaSarre, B., & Federle, M. J. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00046-12 · Cited by 820 · cited 1×
“Quorum quenching (QQ), which disrupts the cell-to-cell communication [quorum sensing (QS)] [9] underlying a wide range of collectively expressed virulence traits, is a PG-targeting ‘antivirulence’ therapy regarded as a promising alternative to conventional bacteriocidal or bacteriostatic treatments [10, 11].”
BackgroundIron and Pseudomonas aeruginosa biofilm formation
Banin, E., Vasil, M. L., & Greenberg, E. P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504266102 · Cited by 801 · cited 1×
“Cornelis, Free University of Brussels, Belgium, as well as versions of the above strains constitutively expressing GFP (PAO1-gfp, PAO1 pvdD-gfp, chromosomal insertion: attTn7::ptac-gfp), and a version of PAO1 with a pvdA-gfp reporter fusion (PAO1pvdA-gfp, chromosomal insertion: attB::pvdA-gfp) [27], provided by P.”
Where will new antibiotics come from?
Walsh, C. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro727 · Cited by 755 · cited 1×
“In light of our results, we contend that this approach—and more generally the extracellular targeting of PGs—could curb microbial virulence in an evolutionarily robust manner, and therefore represents a promising alternative to our dwindling succession of traditional antibiotics [59–61].”
Background
Cited by
Items 101–108 of 108
Targeting biofilms in chronic respiratory infections using drug delivery systems
Loo, C., & Lee, W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820658-4.00006-6
Ancient Pediocin to Innovative Antimicrobial
Kaur, T., & Balgir, P. P. (2021) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-0307-2.ch009
Diettrich, J. C. (2022) · Technische Universität Dortmund Eldorado (Technische Universität Dortmund) · doi:10.17877/de290r-22775
Innovative platforms for drug discovery against mycobacteria: The success and challenges
Nitschke, J., Soldati, T., & Hanna, N. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36518-8.00021-7
Efficiency is better than speed for competitive suppression of drug-resistancePreprint
Cressler, C. E., & Hite, J. L. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.29.728870
Pantović, B. V., Ašanin, D. P., Milisavljević, K. D., Milanović, Ž., Ilic-Tomic, T., Radanović, D. D., Drašković, N. S., Djuran, M. I., & Glišić, B. Đ. (2026) · Polyhedron · doi:10.1016/j.poly.2026.118305
Medicinal and Crop Protection Chemistry: Breaking Barriers, Building Synergies
Cazzaniga, G., Fratello, G. L., Apostle, A. T., Orrù, R., Barber, D. M., & Gazzola, S. (2026) · ChemMedChem · doi:10.1002/cmdc.70441
Ezeanowai, F. C., Ewunkem, A. J., Kiki, L. C., Morikwe, U. C., Ntonifor, M., Graves, J. L., & Jeffers-Francis, L. K. (2026) · Microorganisms · doi:10.3390/microorganisms14112424
Metadata
- Authors
- Ross-Gillespie, A., Weigert, M., Brown, S. P., & Kümmerli, R.
- Affiliations
- University of Zurich (CH)
- Venue
- Evolution, Medicine, and Public Health
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-01-01
- Volume
- 2014
- Issue
- 1
- Pages
- 18-29
- ISSN
- 2050-6201 (ISSN-L)
- PMC
- PMC3935367
- OpenAlex
- W2157642827
- Cited by
- 104
- References
- 63
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 4 · 2021: 8 · 2020: 12 · 2019: 9 · 2018: 7 · 2017: 13 · 2016: 18 · 2015: 12 · 2014: 6
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Evolution Medicine and Public Health (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
- DORA Eawag (Swiss Federal Institute of Aquatic Science and Technology (Eawag)) (submittedVersion, cc-by)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- European Commission
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antimicrobial agents and applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Keywords
- gallium, Pseudomonas aeruginosa, antibiotic resistance, virulence attenuation, Galleria mellonella, experimental evolution, public goods, iron acquisition, antibiotic therapy, bacterial virulence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.